Please login to the form below

Not currently logged in
Email:
Password:

Eli Lilly buys drug patch for $35m

Eli Lilly & Co has announced that it will buy an osteoporosis drug patch from Israeli company TransPharma Medical
Eli Lilly & Co has announced that it will buy an osteoporosis drug patch from Israeli company TransPharma Medical.

The drug contains a hormone that stimulates new bone growth. It is designed to be administered with a special device that creates tiny pores in the skin just prior to applying the patch.

Under the terms of the deal, should the patch gain approval, TransPharma will be eligible for milestone payments.

13th June 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

Improving Outcomes in the Treatment of Opioid Dependence Highlights Report
The 16th annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD)conference took place at the Hilton Madrid Airport hotel on 15–16 May 2018....
Londonvelophobia (fear of cycling in London) – debunked
...
How Helpful are Simple Health Messages?
...

Infographics